1. Home
  2. FSP vs TVGN Comparison

FSP vs TVGN Comparison

Compare FSP & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Street Properties Corp.

FSP

Franklin Street Properties Corp.

N/A

Current Price

$0.37

Market Cap

33.3M

Sector

Real Estate

ML Signal

N/A

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

N/A

Current Price

$6.57

Market Cap

21.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
FSP
TVGN
Founded
1981
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Blank Checks
Sector
Real Estate
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
33.3M
21.3M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
FSP
TVGN
Price
$0.37
$6.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 808.3K
7.7K
Earning Date
10-27-2026
11-13-2026
Dividend Yield
★ 5.31%
N/A
EPS Growth
★ 15.69
N/A
EPS
★ N/A
N/A
Revenue
★ $107,162,000.00
N/A
Revenue This Year
$16.75
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.32
$0.14
52 Week High
$1.70
$12.03

Technical Indicators

Market Signals
Indicator
FSP
TVGN
Relative Strength Index (RSI) 49.15 38.51
Support Level $0.32 $6.22
Resistance Level $0.41 $7.72
Average True Range (ATR) 0.02 0.53
MACD 0.01 -0.16
Stochastic Oscillator 78.91 11.61

Price Performance

Historical Comparison
FSP
TVGN

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: